dokumendiregister.ee
OtsingAsutusedMCP
Otsing›Sotsiaalministeerium
Sissetulev kiriAvalik

Esindaja nimetamine

Sotsiaalministeerium · 23. november 2020
Viit
1.4-2/3362-1
Registreeritud
23. november 2020
Dokumendi liik
Sissetulev kiri
Adressaat
EV alaline esindus EL juures
Saabumis/saatmisviis
e-post
Funktsioon
1.4 EL otsustusprotsess ja rahvusvaheline koostöö
Sari
1.4-2 Rahvusvahelise koostöö korraldamisega seotud kirjavahetus (Arhiiviväärtuslik)
Toimik
1.4-2/2020
Vastutaja
Hanna Alajõe (Sotsiaalministeerium, Kantsleri vastutusvaldkond, Euroopa Liidu ja väliskoostöö osakond)
Lahendamise tähtaeg
29. jaanuar 2021

Failid

  • 📎1123-edastamismeil.msg775 KB
  • 📎E-kiri.pdf68 KB

Sisu (failidest)

Saatja: Obon Roger <[email protected]> Saaja: Esindus EL juures üldaadress, Nominations Teema: Estonia - 2020-11-20 - Nomination invitation for CAT alternate For the attention of HE Mr Rein Tammsaar, Your Excellency, Please find attached a letter from the Executive Director of the European Medicines Agency regarding the nomination of representatives in the Committee for Advanced Therapies (CAT). Kind Regards, [3-EMA banner - option 1]<https://www.ema.europa.eu/en/about-us/history-ema> Roger Obon Experts and Declarations of Interests Management Meeting Secretariat Office Committees and Quality Assurance Department European Medicines Agency Domenico Scarlattilaan 6 | 1083 HS Amsterdam | The Netherlands Telephone +31 (0)88 781 6763 [email protected]<mailto:[email protected]> | www.ema.europa.eu<https://www.ema.europa.eu/en> | For directions, see How to find us<https://www.ema.europa.eu/en/about-us/contact/how-find-us> Follow us: [Twitter-icon] <https://twitter.com/EMA_News> [RSS-icon] <https://www.ema.europa.eu/en/news-event/rss-feeds> [Youtube-icon] <https://www.youtube.com/user/emainfo> This message and any attachment contain information which may be confidential or otherwise protected from disclosure. It is intended for the addressee(s) only and should not be relied upon as legal advice unless it is otherwise stated. If you are not the intended recipient(s) (or authorised by an addressee who received this message), access to this e-mail, or any disclosure or copying of its contents, or any action taken (or not taken) in reliance on it is unauthorised and may be unlawful. If you have received this e-mail in error, please inform the sender immediately. P Please consider the environment before printing this e-mail Classified as confidential by the European Medicines Agency ________________________________________________________________________ This e-mail has been scanned for all known viruses by European Medicines Agency. ________________________________________________________________________ Saatja: Webdesktop <[email protected]> Saadetud: 23.11.2020 13:55 Adressaat: SM Info <[email protected]>; info ravimiamet ee <[email protected]>; <[email protected]>; Elen Ohov <[email protected]> Koopia: <[email protected]> Teema: Webdesktop: Kiri nr 14-4/1123 / Eesti esindaja (CAT alternate) nimetamine Euroopa Ravimiameti uudsete ravimite komiteesse Tere!Edastan Euroopa Ravimiameti kirja. Palun andke enne 01.02.2021 EV AEEL-le teada ([email protected], cc: [email protected]), kas me pikendame praeguse asendusliikme Pille Saaliku mandaati või nimetame uue.Infoks, et just sai pikendatud põhiliikme prof Toivo Maimetsa liikmesust.Reg. number: 14-4/1123Reg. kuupäev: 23.11.2020Sisu: Eesti esindaja nimetamine Euroopa Ravimiameti uudsete ravimite komiteesse (CAT - Committee for Advanced Therapies)Nomination of representatives in the Committee for Advanced Therapies (CAT) of the European Medicines AgencyHeade soovidegaTiiu [email protected]är EV AEEL juures
Allikas: Sotsiaalministeerium dokumendiregister →
dokumendiregister.eeAsutusedEesti avalike dokumendiregistrite otsing · nimistu.ee andmetel